Trial · NCT07896980
MRI-guided Ventricular Tachycardia Ablation in Patients With Structural Heart Disease
NCT07896980, Not applicable, Not yet recruiting, China National Center for Cardiovascular Diseases
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. MRI-guided Ventricular Tachycardia Ablation in Patients With Structural Heart Disease. Trials, record NCT07896980. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07896980
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- MRI-guided Ventricular Tachycardia Ablation in Patients With Structural Heart Disease
- NCT number
- NCT07896980
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 526 participants, estimated
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Conditions
- Ventricular Tachycardia (VT), Ischemic Cardiomyopathy, Non-ischemic Cardiomyopathy
- Interventions
- LGE-MRI-integrated EAM-guided catheter ablation, Conventional EAM-guided catheter ablation
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Composite of ventricular tachycardia recurrence, cardiovascular hospitalization, or death | 12 months after the ablation procedure | VT recurrence is defined as any appropriate ICD therapy (shock or antitachycardia pacing) or documented sustained monomorphic VT lasting more than 30 seconds. Cardiovascular hospitalization is defined as hospital admission after the randomly assigned procedure due to heart failure, procedure-associated complications, or arrhythmic causes. |
| Secondary | Ventricular tachycardia recurrence rate at 6 months | 6 months after the ablation procedure | Proportion of patients with recurrent VT, defined as any appropriate ICD therapy (shock or antitachycardia pacing) or documented sustained monomorphic VT lasting more than 30 seconds. |
| Secondary | Outcomes of the LGE-negative ablation registry cohort compared with the randomized patients | 12 months after the ablation procedure | Prespecified comparison of the composite of VT recurrence, cardiovascular hospitalization, or death between the prospective observational registry of LGE-negative patients undergoing ablation and the randomly assigned (LGE-positive) patients. |
| Secondary | Incidence of ablation-related complications | Within 7 days after the ablation procedure | Incidence of procedure-related adverse events, including pericardial tamponade, pericardial effusion, cardiac perforation, esophageal fistula, and thromboembolism. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers12
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07896980
GET https://conductscience.org/api/trials/v1/NCT07896980/registered